Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia by Locatelli, Franco, Whitlock, James A., Peters, Christina, Chen-Santel, Christiane, Chia, Victoria, Dennis, Robyn M., Heym, Kenneth M., Katz, Aaron J., Kelsh, Michael A., Sposto, Richard, Tu, Huakang, Tuglus, Catherine A., Verma, Anupam, Vinti, Luciana, Wilkes, Jennifer J., Zubarovskaja, Nathalya, Zugmaier, Gerhard, von Stackelberg, Arend, Sun, Weili

Get full text